Sequencing of high-efficacy disease-modifying treatments in MS TrialOCTAVE ConferenceAAN 2019 30 July, 2019 20:12
Tofacitinib: Results from the OCTAVE open-label studies TrialOCTAVE ConferenceECCO 2019 9 May, 2019 19:13